Suppr超能文献

天然香豆素类化合物可乐豆素及其衍生物对碳酸酐酶IX和XII的选择性抑制作用:有前景的抗黑色素瘤和抗胶质母细胞瘤药物

Selective Inhibition of Carbonic Anhydrase IX and XII by Natural Coumarin Coladonin and Its Derivatives: Promising Antimelanoma and Antiglioblastoma Agents.

作者信息

Mustafa Muhamad, Baccari Wiem, Nocentini Alessio, Massardi Maria Luisa, Smietana Michael, Abbass Eslam M, Saidi Ilyes, Znati Mansour, Ben Jannet Hichem, Ronca Roberto, Supuran Claudiu T, Winum Jean-Yves

机构信息

IBMM, Univ Montpellier, CNRS, ENSCM, Montpellier, 34095, France.

Laboratory of Heterocyclic Chemistry, Natural Products and Reactivity (LR11ES39), Team: Medicinal Chemistry and Natural Products, Faculty of Science of Monastir, University of Monastir, Monastir 5000, Tunisia.

出版信息

ACS Med Chem Lett. 2025 May 19;16(6):1190-1196. doi: 10.1021/acsmedchemlett.5c00235. eCollection 2025 Jun 12.

Abstract

Coladonin, a natural sesquiterpene coumarin ether isolated from , along with seven ester derivatives were investigated as inhibitors of human carbonic anhydrases IX and XII (hCA IX/XII). A series of coladonin-derived analogues () was synthesized and tested against five CA isoforms (hCA I, II, IV, IX, XII). Coladonin and its trifluoracetyl derivative strongly and selectively inhibited hCA IX ( = 90 and 70 nM, respectively) and hCA XII ( = 210 and 110 nM, respectively). Compound exhibited better selectivity on hCA IX than acetazolamide (). The antimelanoma and antiglioblastoma efficacy of coladonin and was evaluated under hypoxic conditions. Both compounds displayed significant antiproliferative effects, markedly better than those of the reference hCA IX/XII inhibitor currently in clinical phase IIb. These results highlight coladonin as a promising scaffold for developing selective hCA IX/XII inhibitors targeting hypoxic tumors.

摘要

从[具体来源未给出]中分离得到的天然倍半萜香豆素醚类化合物可乐豆宁(Coladonin)以及七种酯衍生物,被作为人碳酸酐酶IX和XII(hCA IX/XII)的抑制剂进行了研究。合成了一系列可乐豆宁衍生类似物([具体内容未给出]),并针对五种CA同工型(hCA I、II、IV、IX、XII)进行了测试。可乐豆宁及其三氟乙酰衍生物[具体编号未给出]分别强烈且选择性地抑制hCA IX(IC50分别为90和70 nM)和hCA XII(IC50分别为210和110 nM)。化合物[具体编号未给出]对hCA IX的选择性优于乙酰唑胺([具体内容未给出])。在缺氧条件下评估了可乐豆宁[具体编号未给出]和[具体编号未给出]的抗黑色素瘤和抗胶质母细胞瘤疗效。这两种化合物均显示出显著的抗增殖作用,明显优于目前处于临床IIb期的参考hCA IX/XII抑制剂[具体内容未给出]。这些结果突出了可乐豆宁[具体编号未给出]作为开发针对缺氧肿瘤的选择性hCA IX/XII抑制剂的有前景的骨架。

相似文献

本文引用的文献

3
Targeting carbonic anhydrases for the management of hypoxic metastatic tumors.针对缺氧转移瘤的碳酸酐酶靶向治疗。
Expert Opin Ther Pat. 2023 Nov;33(11):701-720. doi: 10.1080/13543776.2023.2245971. Epub 2023 Aug 12.
5
Emerging role of carbonic anhydrase inhibitors.碳酸酐酶抑制剂的新作用
Clin Sci (Lond). 2021 May 28;135(10):1233-1249. doi: 10.1042/CS20210040.
6
Natural products in drug discovery: advances and opportunities.天然产物在药物发现中的应用:进展与机遇。
Nat Rev Drug Discov. 2021 Mar;20(3):200-216. doi: 10.1038/s41573-020-00114-z. Epub 2021 Jan 28.
8
Coumarin carbonic anhydrase inhibitors from natural sources.天然来源的香豆素碳酸酐酶抑制剂。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1462-1470. doi: 10.1080/14756366.2020.1788009.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验